Cathie Wood: portfolio of ARK Investment Management
Cathie Wood leads ARK Investment Management, which offers actively managed funds focused on technology and innovation.
Source: 13F filing with the US Securities and Exchange Commission dated Feb 1, 2019. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary Amended on Feb 11, 2019 – the version known today is shown.
You are looking at Q4 2018. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 2.5B USD
- Positions
- 194
- Share of the ten largest
- 44.6%
The ten largest positions Q4 2018
- Tesla, Inc. 5.6%▼ −44.5%
- Nvidia 5.0%▲ +186.7%
- Stratasys Ltd 5.0%▼ −2.0%
- Block, Inc. 4.9%▲ +107.0%
- Baidu (ADR) 4.7%▲ +19.7%
- Tencent Holdings Ltd 4.2%▼ −4.0%
- Invitae Corp 3.9%▼ −4.4%
- Illumina, Inc. 3.9%▲ +16.9%
- Intellia Therapeutics Inc 3.8%▲ +18.2%
- Twitter Inc 3.8%▼ −21.8%
Show all positions of this quarter
Choose a quarter (40 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
All positions Q4 2018
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| NVDA Nvidia | 5.0% | 914,128 | 122.0M USD | +186.7% increased | Q4 2016 or earlier 9 quarters |
| XYZ Block, Inc. | 4.9% | 2,135,920 | 119.8M USD | +107.0% increased | Q4 2016 or earlier 9 quarters |
| BIDU Baidu (ADR) | 4.7% | 729,440 | 115.7M USD | +19.7% increased | Q4 2016 or earlier 9 quarters |
| ILMN Illumina, Inc. | 3.9% | 316,640 | 95.0M USD | +16.9% increased | Q4 2016 or earlier 9 quarters |
| Intellia Therapeutics Inc | 3.8% | 6,801,952 | 92.8M USD | +18.2% increased | Q4 2016 or earlier 9 quarters |
| TER Teradyne | 3.3% | 2,590,588 | 81.3M USD | +49.6% increased | Q4 2016 or earlier 9 quarters |
| NFLX Netflix | 2.8% | 262,225 | 70.2M USD | +27.5% increased | Q4 2016 or earlier 9 quarters |
| Editas Medicine Inc | 2.8% | 3,024,489 | 68.8M USD | +8.3% increased | Q1 2017 8 quarters |
| AMZN Amazon | 2.6% | 42,817 | 64.3M USD | +12.5% increased | Q4 2016 or earlier 9 quarters |
| Medidata Solutions Inc | 2.6% | 936,559 | 63.1M USD | +16.5% increased | Q4 2016 or earlier 9 quarters |
| Zillow Group Inc | 2.3% | 1,821,356 | 57.5M USD | +84.4% increased | Q2 2018 3 quarters |
| Splunk Inc | 2.1% | 498,136 | 52.2M USD | +38.6% increased | Q4 2016 or earlier 9 quarters |
| LendingTree Inc | 2.1% | 235,501 | 51.7M USD | +60.0% increased | Q4 2016 or earlier 9 quarters |
| CRM Salesforce | 2.0% | 354,169 | 48.5M USD | +40.8% increased | Q4 2016 or earlier 9 quarters |
| Spotify Technology SA | 1.8% | 395,842 | 44.9M USD | +42.6% increased | Q2 2018 3 quarters |
| Cerus Corp | 1.4% | 6,740,782 | 34.2M USD | +3.7% increased | Q4 2016 or earlier 9 quarters |
| Teladoc Health Inc | 1.3% | 658,407 | 32.6M USD | +633.3% increased | Q3 2017 6 quarters |
| 2U Inc | 1.2% | 570,214 | 28.4M USD | +202.4% increased | Q4 2016 or earlier 9 quarters |
| Seres Therapeutics Inc | 0.8% | 4,119,479 | 18.6M USD | +1.9% increased | Q4 2016 or earlier 9 quarters |
| Organovo Holdings Inc | 0.7% | 18,059,829 | 17.3M USD | +0.6% increased | Q4 2016 or earlier 9 quarters |
| Compugen Ltd | 0.6% | 7,105,958 | 15.4M USD | +2.9% increased | Q4 2016 or earlier 9 quarters |
| Syros Pharmaceuticals Inc | 0.6% | 2,460,621 | 13.7M USD | +10.7% increased | Q4 2016 or earlier 9 quarters |
| Ionis Pharmaceuticals Inc | 0.5% | 242,312 | 13.1M USD | +5.7% increased | Q4 2016 or earlier 9 quarters |
| Celgene Corp | 0.5% | 174,303 | 11.2M USD | +17.8% increased | Q4 2016 or earlier 9 quarters |
| GrubHub Inc | 0.4% | 112,983 | 8.7M USD | +337.2% increased | Q3 2018 2 quarters |
| Aerovironment Inc | 0.3% | 115,625 | 7.9M USD | +11.8% increased | Q4 2016 or earlier 9 quarters |
| IOVA Iovance Biotherapeutics | 0.3% | 726,360 | 6.4M USD | +71.0% increased | Q1 2018 4 quarters |
| Zuora Inc | 0.2% | 309,589 | 5.6M USD | +3.4% increased | Q2 2018 3 quarters |
| Rubius Therapeutics Inc | 0.2% | 315,152 | 5.1M USD | +67.4% increased | Q3 2018 2 quarters |
| INCY Incyte | 0.2% | 66,147 | 4.2M USD | +3.9% increased | Q4 2016 or earlier 9 quarters |
| ALGN Align Technology | 0.2% | 18,914 | 4.0M USD | +57.9% increased | Q4 2016 or earlier 9 quarters |
| Arcturus Therapeutics Ltd | 0.1% | 815,176 | 3.7M USD | +5.4% increased | Q4 2017 5 quarters |
| Pluristem Therapeutics Inc | 0.1% | 3,387,094 | 2.7M USD | +17.1% increased | Q3 2017 6 quarters |
| Cognex Corp | 0.1% | 68,945 | 2.7M USD | +14.3% increased | Q4 2017 5 quarters |
| Renishaw PLC | < 0.1% | 43,889 | 2.4M USD | +17.1% increased | Q3 2017 6 quarters |
| ISRG Intuitive Surgical | < 0.1% | 4,926 | 2.4M USD | +36.5% increased | Q2 2018 3 quarters |
| MGI Digital Graphic Technology | < 0.1% | 44,342 | 2.1M USD | +24.6% increased | Q1 2018 4 quarters |
| Prodways Group SA | < 0.1% | 644,576 | 1.9M USD | +17.2% increased | Q3 2017 6 quarters |
| Rakuten Inc | < 0.1% | 269,521 | 1.8M USD | 0.0% increased | Q1 2018 4 quarters |
| Kratos Defense & Security Solu | < 0.1% | 119,953 | 1.7M USD | +61.9% increased | Q3 2018 2 quarters |
| Dassault Systemes SE | < 0.1% | 12,267 | 1.5M USD | +0.8% increased | Q3 2017 6 quarters |
| SLM Solutions Group AG | < 0.1% | 126,097 | 1.3M USD | +61.4% increased | Q3 2017 6 quarters |
| SYK Stryker Corporation | < 0.1% | 5,084 | 797.0K USD | +50.9% increased | Q1 2018 4 quarters |
| Mellanox Technologies Ltd | < 0.1% | 6,857 | 633.0K USD | +5.7% increased | Q4 2016 or earlier 9 quarters |
| AquaBounty Technologies Inc | < 0.1% | 294,914 | 605.0K USD | +19.2% increased | Q1 2018 4 quarters |
| Nano Dimension Ltd | < 0.1% | 513,079 | 570.0K USD | 0.0% increased | Q4 2016 or earlier 9 quarters |
| Orbotech Ltd | < 0.1% | 8,940 | 505.0K USD | +3.7% increased | Q4 2017 5 quarters |
| Evogene Ltd | < 0.1% | 252,122 | 499.0K USD | +3.9% increased | Q4 2016 or earlier 9 quarters |
| Radware Ltd | < 0.1% | 21,406 | 486.0K USD | +8.5% increased | Q4 2017 5 quarters |
| UroGen Pharma Ltd | < 0.1% | 11,298 | 486.0K USD | +0.4% increased | Q4 2017 5 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Show more (up to 500) Shown: the 50 largest of 73 positions.
Breakdown by sector
- Technology 12.8%
- Consumer Discretionary 8.5%
- Financials 5.3%
- Health Care 4.8%
- Communication Services 3.0%
- Industrials 0.1%
- Materials < 0.1%
- not in our coverage 65.4%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors